Bree Foster, PhD
Bree Foster is a science writer at Drug Discovery News with over 2 years of experience at Technology Networks, Drug Discovery News, and other scientific marketing agencies. She holds a PhD in comparative and functional genomics from the University of Liverpool and enjoys crafting compelling stories for science.
Articles by Bree Foster, PhD
| 5 min read
Explore the mechanisms, clinical applications, and future opportunities of GLP-1 receptor agonists in drug development and disease management.
| 3 min read
How a team at Pfizer turned a decade-old compound into the fastest small molecule drug for COVID-19.
| 4 min read
Researchers are turning bacterial transport systems from obstacles into opportunities for targeted therapy.
| 4 min read
Scientists are using insights from viral hijacking to chemically reprogram E3 ligases, opening new opportunities in drug discovery.
| 5 min read
After a decade of promise, AAV therapies are now confronting economic, clinical, and regulatory hurdles.
| 6 min read
Advances in biofabrication and regulatory momentum are accelerating the move from 2D cultures and animal models to scalable, human-relevant systems.
| 3 min read
A team from Stanford and NYU shows how Bacteroides fragilis can activate pain pathways, revealing a new microbial culprit in digestive disease.
| 3 min read
Structural insights reveal how DCAF2 can be harnessed to target previously untouchable proteins for degradation.
| 6 min read
By combining 3D biofabrication with perfusable vasculature, researchers are paving the way for fully implantable organs.
| 7 min read
With blockbuster status secured, GLP-1 therapies face new questions about efficacy, delivery, and their role in treating multiple chronic diseases.
| 5 min read
Advances in allosteric inhibitors may offer a new standard of care that balances potent disease control with better tolerability and convenience.
| 3 min read
A novel cannabis-based therapy shows promise as a safe, effective non-opioid alternative for chronic low back pain.
